New oral anti-coagulation drugs and prostate biopsy: a call for guidelines.

Coscarella, Mathieu; Motte, Serge; Dalati, Mohamad-Fadi; Oliveira-E-Silva, Tania; Entezari, Kim; Roumeguere, Thierry

Coscarella, Mathieu; Motte, Serge; Dalati, Mohamad-Fadi; Oliveira-E-Silva, Tania; Entezari, Kim; Roumeguere, Thierry.

Afiliação

Coscarella M; Department of Urology, Erasme Hospital, University Clinics of Brussels, Route de Lennik 808, 1070 Brussels, Belgium Department of Urology, CHU St Pierre, Université Libre de Bruxelles, Brussels, Belgium.
Motte S; Department of Vascular Diseases, University Clinics of Brussels, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.
Dalati MF; Department of Urology, CHU Saint Pierre, Université Libre de Bruxelles, Brussels, Belgium.
Oliveira-E-Silva T; Department of Urology, CHU Saint Pierre, Université Libre de Bruxelles, Brussels, Belgium.
Entezari K; Department of Urology, CHU Saint Pierre, Université Libre de Bruxelles, Brussels, Belgium.
Roumeguere T; Department of Urology, University Clinics of Brussels, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.

Ther Adv Urol ; 10(12): 437-443, 2018 Dec.

Article em En | MEDLINE | ID: mdl-30574204

Palavras-chave

complications; new oral anti-coagulant (NOAC); prostate biopsy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Ther Adv Urol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Bélgica

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google